These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21554421)

  • 1. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.
    Mikolajewska A; Schwartz S; Ruhnke M
    Mycoses; 2012 Jan; 55(1):2-16. PubMed ID: 21554421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical critique of antifungal treatment guidelines for haemato-oncologists.
    Agrawal S; Jones B; Barnes R; Kibbler C; Millen M; Ashcroft M; Jain S; Last A; Lewis D; Lewis T; Patel M; Pagliuca A
    Crit Rev Microbiol; 2012 Aug; 38(3):203-16. PubMed ID: 22324737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in the ICU: advances in treatment and diagnosis.
    De Pascale G; Tumbarello M
    Curr Opin Crit Care; 2015 Oct; 21(5):421-9. PubMed ID: 26165502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin use in children.
    Emiroglu M
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y; Zimmerli S
    Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current options for antifungal therapy of invasive candidiasis in intensive care units].
    Hamal P; Raclavský V; Svobodová L; Koukalová D
    Klin Mikrobiol Infekc Lek; 2010 Oct; 16(5):164-70. PubMed ID: 21191874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
    Einsele H; Loeffler J
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.
    Glöckner A; Karthaus M
    Mycoses; 2011 Sep; 54(5):420-33. PubMed ID: 20492530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.
    Oz Y; Kiraz N
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):289-98. PubMed ID: 21417868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Rogers TR; Slavin MA; Donnelly JP
    Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
    Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
    PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis complicating neoplastic disease.
    Pursell KJ
    Semin Respir Infect; 1992 Jun; 7(2):96-103. PubMed ID: 1439324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal stewardship in invasive Candida infections.
    Ruhnke M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():11-8. PubMed ID: 24661820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.